Literature DB >> 22700433

15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.

Priyadarshini Raman1, Barbara L F Kaplan, Norbert E Kaminski.   

Abstract

2-Arachidonyl glycerol (2-AG) is an endogenous arachidonic acid derivative released on demand from membrane precursors. 2-AG-mediated suppression of interleukin (IL)-2 depends on cyclooxygenase 2 (COX-2) metabolism and peroxisome proliferator-activated receptor γ (PPARγ) activation. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol ester (15d-PGJ₂-G), a putative COX-2 metabolite of 2-AG, acts as a PPARγ ligand and produces IL-2 suppression in activated Jurkat T cells, in part, by decreasing nuclear factor of activated T cells (NFAT) transcriptional activity. The objective of the present studies was to investigate the mechanism by which 15d-PGJ₂-G modulates NFAT activity to suppress IL-2. 15d-PGJ₂-G treatment decreased phorbol 12-myristate 13-acetate (PMA)/calcium ionophore (I₀)-induced NFAT DNA binding to the human IL-2 promoter and nuclear NFAT2 accumulation. It is noteworthy that 15d-PGJ₂-G treatment increased active nuclear HDM2 (human homolog of the oncoprotein and E3 ubiquitin ligase murine double minute 2) expression, whereas there was no change in the expression of glycogen synthase kinase 3β, both of which regulate NFAT. 15d-PGJ₂-G and other PPARγ agonists, such as rosiglitazone and ciglitazone, decreased PMA/I₀-mediated elevation in intracellular calcium concentration ([Ca²⁺](i)) in activated Jurkat cells. We were surprised to find that the PPARγ antagonists 2-chloro-5-nitro-N-4-pyridinylbenzamide (T0070907) and 2-chloro-5-nitrobenzanilide (GW9662) also decreased the PMA/I₀-mediated elevation in [Ca²⁺](i) in activated T cells. In addition, the presence of T0070907 plus 15d-PGJ₂-G produced an additive decrease in PMA/I₀-mediated elevation of [Ca²⁺](i), suggesting that the 15d-PGJ₂-G effects on calcium might be either PPARγ-independent or -dependent on occupation of the PPARγ ligand binding domain. Collectively, our findings suggest that 15d-PGJ₂-G increases active nuclear HDM2, which could lead to a decrease in NFAT2 and IL-2 suppression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700433      PMCID: PMC3422518          DOI: 10.1124/jpet.112.193003

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

Review 1.  PPARgamma in immunity and inflammation: cell types and diseases.

Authors:  Lajos Széles; Dániel Töröcsik; László Nagy
Journal:  Biochim Biophys Acta       Date:  2007-02-24

2.  Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.

Authors:  Tristano Pancani; Jeremiah T Phelps; James L Searcy; Michael W Kilgore; Kuey-Chu Chen; Nada M Porter; Olivier Thibault
Journal:  J Neurochem       Date:  2009-05-11       Impact factor: 5.372

3.  Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation.

Authors:  S Hauser; G Adelmant; P Sarraf; H M Wright; E Mueller; B M Spiegelman
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

4.  Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

Authors:  X Y Yang; L H Wang; T Chen; D R Hodge; J H Resau; L DaSilva; W L Farrar
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

5.  Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.

Authors:  Cheryl E Rockwell; Natasha T Snider; Jerry T Thompson; John P Vanden Heuvel; Norbert E Kaminski
Journal:  Mol Pharmacol       Date:  2006-04-12       Impact factor: 4.436

6.  Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.

Authors:  M Lee; K H Yang; N E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

7.  Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells.

Authors:  Carla Cristine Kanunfre; Jofre Jacob da Silva Freitas; Celine Pompéia; Débora Cristina Gonçalves de Almeida; Maria Fernanda Cury-Boaventura; Rozangela Verlengia; Rui Curi
Journal:  Int Immunopharmacol       Date:  2004-09       Impact factor: 4.932

8.  REAP: A two minute cell fractionation method.

Authors:  Keiko Suzuki; Pinaki Bose; Rebecca Yy Leong-Quong; Donald J Fujita; Karl Riabowol
Journal:  BMC Res Notes       Date:  2010-11-10

9.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

10.  Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation.

Authors:  Jianhua Feng; Rastislav Tamaskovic; Zhongzhou Yang; Derek P Brazil; Adrian Merlo; Daniel Hess; Brian A Hemmings
Journal:  J Biol Chem       Date:  2004-05-28       Impact factor: 5.157

View more
  8 in total

1.  Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-30       Impact factor: 4.219

Review 2.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

3.  Increase in Cellular Lysophosphatidylserine Content Exacerbates Inflammatory Responses in LPS-Activated Microglia.

Authors:  Tomoki Minamihata; Katsura Takano; Yoichi Nakamura; Ryoya Seto; Mitsuaki Moriyama
Journal:  Neurochem Res       Date:  2021-08-12       Impact factor: 4.414

4.  Lipopolysaccharide suppresses carboxylesterase 2g activity and 2-arachidonoylglycerol hydrolysis: A possible mechanism to regulate inflammation.

Authors:  Brittany Szafran; Abdolsamad Borazjani; Jung Hwa Lee; Matthew K Ross; Barbara L F Kaplan
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-09-25       Impact factor: 3.072

Review 5.  Polyunsaturated Fatty Acid-derived lipid mediators and T cell function.

Authors:  Anna Nicolaou; Claudio Mauro; Paula Urquhart; Federica Marelli-Berg
Journal:  Front Immunol       Date:  2014-02-25       Impact factor: 7.561

6.  Crosstalk between PPARγ Ligands and Inflammatory-Related Pathways in Natural T-Regulatory Cells from Type 1 Diabetes Mouse Model.

Authors:  S Zulkafli Nor Effa; Nik Soriani Yaacob; Norazmi Mohd Nor
Journal:  Biomolecules       Date:  2018-11-05

7.  Electronic-Cigarette Vehicles and Flavoring Affect Lung Function and Immune Responses in a Murine Model.

Authors:  Brittany N Szafran; Rakeysha Pinkston; Zakia Perveen; Matthew K Ross; Timothy Morgan; Daniel B Paulsen; Arthur L Penn; Barbara L F Kaplan; Alexandra Noël
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923

8.  Limited Applicability of GW9662 to Elucidate PPARγ-Mediated Fatty Acid Effects in Primary Human T-Helper Cells.

Authors:  Anke Jaudszus; Stefan Lorkowski; Michael Gruen; Alexander Roth; Gerhard Jahreis
Journal:  Int J Inflam       Date:  2014-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.